Philips, SAM open regional oncology centre in Singapore
Advanced imaging technologies realize accurate and timely diagnosis of cancer
Royal
Philips, a global leader in health technology, and the Singapore Institute of
Advanced Medicine Holdings (SAM) officially opened the Advanced Medicine
Imaging (AMI) centre at Biopolis, an international biomedical research hub in
Singapore. The new facility will provide specialized oncology care to the
fast-growing number of people confronted with cancer in the Southeast Asia
region. In addition, the centre will facilitate scientific research and
development and provide medical training targeted at upskilling the region’s
healthcare professionals in the newest cancer therapies. The facilities, which
will open in phases, are scheduled for completion by the end of 2019.
With
a comprehensive portfolio of advanced imaging systems and clinical informatics,
the AMI centre will empower clinicians to deliver fast and robust oncology
imaging. It will house two Philips Vereos PET/CT scanners, the world’s first
and only fully digital PET/CT systems. Another world-first solution at AMI is
Philips’ IQon Spectral CT, a new generation Computed Tomography (CT) solution
that allows clinicians to characterize tumors with greater certainty than is
possible with black and white images from conventional CT scans. Philips’ IQon Spectral CT is also the world's
first spectral detector-based CT that allows clinicians to do both in-depth
spectral information on demand and retrospective analysis at low-dose – a
direct benefit to patients.
To read more please visit:
Source: Biospectrum